Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma entities : Royalty pharma plc save search
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 1.07%
H: 1.22%
C: 1.11%
first pharma royalty financial results
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.08%
C: -1.17%
pharma conference health care royalty
Royalty Pharma Reports Q4 and Full Year 2023 Results
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 1.26%
H: 3.99%
C: 1.21%
pharma year royalty results
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
Published: 2024-01-30 (Crawled : 21:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.49%
H: 0.14%
C: -0.94%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.07%
H: 0.44%
C: -1.08%
pharma year royalty financial results
Royalty Pharma Announces Dividend Increase
Published: 2024-01-19 (Crawled : 13:30) - royaltypharma.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.57%
H: 3.21%
C: 3.09%
pharma royalty
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.0%
H: 1.84%
C: 1.82%
pharma conference business update royalty
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
Published: 2023-11-27 (Crawled : 21:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.04%
H: 0.39%
C: -0.15%
pharma conference royalty
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
Published: 2023-11-13 (Crawled : 13:30) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M
|
Health Technology
|
| O: -0.92%
H: 4.53%
C: 2.56%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.44%
H: 0.59%
C: 0.04%
pharma royalty teva program
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.44%
H: 0.59%
C: 0.04%
pharma royalty teva program
Royalty Pharma Reports Third Quarter 2023 Results
Published: 2023-11-08 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.66%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -1.38%
H: 1.77%
C: 1.66%
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -3.21%
ASND | $145.17 2.16% 2.11% 220K
|
Health Technology
|
| O: -1.78%
H: 1.24%
C: 0.32%
pharma royalty results
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi
Published: 2023-10-19 (Crawled : 12:00) - globenewswire.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: -0.57%
H: 1.09%
C: 0.98%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: 1.4%
H: 0.53%
C: -0.81%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.15%
H: 3.45%
C: 2.22%
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
|
| O: 3.46%
H: 19.19%
C: 11.13%
pharma royalty evrysdi agreement
Royalty Pharma Declares Fourth Quarter 2023 Dividend
Published: 2023-10-16 (Crawled : 20:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.11%
H: 2.08%
C: 1.97%
pharma royalty
Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
Published: 2023-10-11 (Crawled : 20:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.15%
H: 0.22%
C: -0.29%
pharma royalty financial results
Royalty Pharma Appoints Eric Schneider as Chief Technology Officer
Published: 2023-09-21 (Crawled : 12:30) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.52%
H: 0.57%
C: -0.56%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.38%
H: 0.02%
C: -3.97%
pharma royalty technology
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
Published: 2023-09-05 (Crawled : 20:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.41%
H: 0.07%
C: -1.86%
ASND | $145.17 2.16% 2.11% 220K
|
Health Technology
|
| O: 3.69%
H: 2.93%
C: 0.53%
pharma royalty funding agreement
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
Published: 2023-09-05 (Crawled : 20:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.41%
H: 0.07%
C: -1.86%
ASND | $145.17 2.16% 2.11% 220K
|
Health Technology
|
| O: 3.69%
H: 2.93%
C: 0.53%
pharma royalty funding agreement
Royalty Pharma to Present at Upcoming Investor Conferences
Published: 2023-09-05 (Crawled : 12:30) - globenewswire.com
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.17%
H: 0.2%
C: -2.38%
pharma royalty
Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
Published: 2023-08-24 (Crawled : 08:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.72%
C: -0.4%
adstiladrin pharma pharmaceuticals royalty agreement therapy
Royalty Pharma Reports Second Quarter 2023 Results
Published: 2023-08-08 (Crawled : 11:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
pharma royalty results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.